Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

NCT00163501 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Perennial Allergic Rhinitis
Allergic Rhinitis
Hay Fever

Interventions

DRUG: Ciclesonide

Sponsor

AstraZeneca